Skip to Main Content

Author Details

Aleksandra A Pandyra
Hematology and Clinical Immunology, Heinrich-Heine University Dusseldorf
2003
50
17
PMIDPaper TitleJournal TitlePublished Year
36741356Cytokine Hyperresponsiveness in Children With ETV6::RUNX1-positive Acute Lymphoblastic Leukemia After Challenge With Common Pathogens.Hemasphere2023
37656187Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytoma.Acta Neuropathol2023
37582744Unleashing T cell anti-tumor immunity: new potential for 5-Nonloxytryptamine as an agent mediating MHC-I upregulation in tumors.Mol Cancer2023
37439330Worms on stage.Haematologica2023
37033933Arenaviruses: Old viruses present new solutions for cancer therapy.Front Immunol2023
34810198BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment.Cancer Res2022
35454869Communicator-Driven Data Preprocessing Improves Deep Transfer Learning of Histopathological Prediction of Pancreatic Ductal Adenocarcinoma.Cancers (Basel)2022
35166071Single MHC-I Expression Promotes Virus-Induced Liver Immunopathology.Hepatol Commun2022
33918368Deep Transfer Learning Approach for Automatic Recognition of Drug Toxicity and Inhibition of SARS-CoV-2.Viruses2021
33927339Slow viral propagation during initial phase of infection leads to viral persistence in mice.Commun Biol2021
31409605Fragile X mental retardation protein protects against tumour necrosis factor-mediated cell death and liver injury.Gut2020
32085796Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications.J Exp Clin Cancer Res2020
31954207A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus control.J Hepatol2020
33008037Senescent Tumor CD8<sup>+</sup> T Cells: Mechanisms of Induction and Challenges to Immunotherapy.Cancers (Basel)2020
32973762Arenavirus Induced CCL5 Expression Causes NK Cell-Mediated Melanoma Regression.Front Immunol2020
32911536An intact gut microbiome protects genetically predisposed mice against leukemia.Blood2020
32749766Cyclic AMP-hydrolyzing phosphodiesterase inhibitors potentiate statin-induced cancer cell death.Mol Oncol2020
32529300Glucose transport in lymphocytes.Pflugers Arch2020
32117809NK Cells Regulate CD8<sup>+</sup> T Cell Mediated Autoimmunity.Front Cell Infect Microbiol2020
30829412Reply.Hepatology2019
31662486iRhom2 inhibits bile duct obstruction-induced liver fibrosis.Sci Signal2019
31484831Progranulin prevents regulatory NK cell cytotoxicity against antiviral T cells.JCI Insight2019
29142134Tumor Necrosis Factor-Mediated Survival of CD169<sup>+</sup> Cells Promotes Immune Activation during Vesicular Stomatitis Virus Infection.J Virol2018
30111770Cholestasis induced liver pathology results in dysfunctional immune responses after arenavirus infection.Sci Rep2018
30504710Phosphate Homeostasis, Inflammation and the Regulation of FGF-23.Kidney Blood Press Res2018
29742809B Cell-Mediated Maintenance of Cluster of Differentiation 169-Positive Cells Is Critical for Liver Regeneration.Hepatology2018
28704812SGLT1 Deficiency Turns Listeria Infection into a Lethal Disease in Mice.Cell Physiol Biochem2017
28248314Spatiotemporally restricted arenavirus replication induces immune surveillance and type I interferon-dependent tumour regression.Nat Commun2017
29186689Lymphocytes Negatively Regulate NK Cell Activity via Qa-1b following Viral Infection.Cell Rep2017
27606466RAIDD Mediates TLR3 and IRF7 Driven Type I Interferon Production.Cell Physiol Biochem2016
25065608Conjugated bilirubin triggers anemia by inducing erythrocyte death.Hepatology2015
26353928Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell death.Oncotarget2015
26535007Deletions in the cytoplasmic domain of iRhom1 and iRhom2 promote shedding of the TNF receptor by the protease ADAM17.Sci Signal2015
25673724Deficiency of the B cell-activating factor receptor results in limited CD169+ macrophage function during viral infection.J Virol2015
25692415CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production.Nat Commun2015
25257173Toso regulates differentiation and activation of inflammatory dendritic cells during persistence-prone virus infection.Cell Death Differ2015
23435422MYC activity is negatively regulated by a C-terminal lysine cluster.Oncogene2014
27308369Targeting tumor cell metabolism via the mevalonate pathway: Two hits are better than one.Mol Cell Oncol2014
24994712Immediate utility of two approved agents to target both the metabolic mevalonate pathway and its restorative feedback loop.Cancer Res2014
24909887Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity.Immunity2014
24531538IRF4 and BATF are critical for CD8⁺ T-cell function following infection with LCMV.Cell Death Differ2014
23328631Reactive oxygen species delay control of lymphocytic choriomeningitis virus.Cell Death Differ2013
24003457Reply to Honjo et al.: Functional relevant expression of Toso on granulocytes.Proc Natl Acad Sci U S A2013
23359703Involvement of Toso in activation of monocytes, macrophages, and granulocytes.Proc Natl Acad Sci U S A2013
20360469Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myeloma.Blood2010
20696928Dysregulation of the mevalonate pathway promotes transformation.Proc Natl Acad Sci U S A2010
17452420Combination silencer RNA (siRNA) targeting Bcl-2 antagonizes siRNA against thymidylate synthase in human tumor cell lines.J Pharmacol Exp Ther2007
16312022Intercalation of daunomycin into d(CG)4 oligomer duplex containing G x T mismatches by vibrational circular dichroism and infrared absorption spectroscopy.Biopolymers2006
16013055Isotope-labeled vibrational circular dichroism studies of calmodulin and its interactions with ligands.Biopolymers2005
12688806Regiochemical switching in Diels-Alder cycloadditions by change in oxidation state of removable diene sulfur substituents. Synthesis of carbazoles by sequential heteroannulation and Diels-Alder cycloaddition.J Org Chem2003
  • 1 - 50 of 50

Recommended Authors

Zaid Taha
Ottawa Hospital Research Institute, University of Ottawa
Career Start Year 2018
Number of shared co-authors 1
Ang Cui
Massachusetts Institute of Technology
Career Start Year 2013
Number of shared co-authors 1
Nehme El-Hachem
Centre Hospitalier Universitaire Sainte-Justine Research Centre
Career Start Year 2011
Number of shared co-authors 1
Huiyuan Zhang
Texas Children's Cancer Center
Career Start Year 2010
Number of shared co-authors 1
Daniel D'Andrea
Nottingham Trent University
Career Start Year 2010
Number of shared co-authors 1
Jianying Zhang
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 1
Lili Yang
University of California Los Angeles
Career Start Year 2009
Number of shared co-authors 1
Shweta Joshi
Moores Cancer Center, University of California
Career Start Year 2007
Number of shared co-authors 0
Isabelle Martins
Universite de Paris, Sorbonne Universite, Inserm U8, Institut Universitaire de France
Career Start Year 2007
Number of shared co-authors 0
Min Luo
Institute of Biomedical Science and Children's Hospital, Fudan University
Career Start Year 2006
Number of shared co-authors 1
Maggie Cam
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 0
Andrew V Kossenkov
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 1
Yongmei Feng
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2002
Number of shared co-authors 1
Chandra C Ghosh
The Wistar Institute
Career Start Year 1999
Number of shared co-authors 0
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 1
Priya Ranjan
Pondicherry University
Career Start Year 1997
Number of shared co-authors 0
Renee C Ireton
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 1997
Number of shared co-authors 0
Seunghee Kim-Schulze
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 1
Jenny Xiang
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 1993
Number of shared co-authors 0
Zhiqiang An
Zhengzhou University
Career Start Year 1992
Number of shared co-authors 0
Veena Kapoor
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 0
Ricky W Johnstone
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 0
Nir Hacohen
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 2
Daniel S Peeper
Netherlands Cancer Institute
Career Start Year 1987
Number of shared co-authors 0
Thomas Decker
University of Vienna
Career Start Year 1985
Number of shared co-authors 0
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 0
Stephen E Kurtz
Knight Cancer Institute, Oregon Health and Science University
Career Start Year 1979
Number of shared co-authors 1
Judy Lieberman
Boston Children's Hospital
Career Start Year 1978
Number of shared co-authors 0
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 5
Norman E Sharpless
National Cancer Institute
Career Start Year 1945
Number of shared co-authors 0

Collaborators

Tak W Mak
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 12
Arndt Borkhardt
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Co-authored papers 11
Linda Z Penn
University of Toronto
Co-authored papers 8
Daniel Picard
Groupe Hospitalier Universitaire Pitie-Salpetriere
Co-authored papers 4
Marc Remke
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 3
Manpreet Kalkat
Van Andel Institute
Co-authored papers 3
Ute Fischer
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Co-authored papers 3
Kai St??hler
Universitatsklinikum
Co-authored papers 3
Carl F Ware
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 3
Garry P Nolan
Stanford University School of Medicine
Co-authored papers 2
Zhihua Li
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
James W Clendening
The Ontario Cancer Institute, Princess Margaret Hospital, University of Toronto
Co-authored papers 2
Aaron D Schimmer
Princess Margaret Cancer Centre
Co-authored papers 2
Dirk Schadendorf
Co-authored papers 2
Suzanne Trudel
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Paul C Boutros
University of California los angeles
Co-authored papers 2
Igor Jurisica
Schroeder Arthritis Institute
Co-authored papers 2
Anna Martirosyan
West Virginia University
Co-authored papers 2
Peter J Mullen
University of St Andrews
Co-authored papers 2
Carolyn A Goard
Princess Margaret Cancer Centre, Ontario Cancer Institute
Co-authored papers 1
Samah El Ghamrasni
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Ulf Dittmer
University Hospital Essen, University of Duisburg-Essen, Institute for Virology
Co-authored papers 1
Kevin R Brown
College Street, University of Toronto
Co-authored papers 1
Anja Stefanski
Universitatsklinikum
Co-authored papers 1
Grace A Trentin
3Allergan Inc.,Markham,Ontario,Canada.
Co-authored papers 1
Frauke-Dorothee Meyer
German Cancer Research Center (DKFZ)
Co-authored papers 1
Razqallah Hakem
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 1
Fereshteh Khosravi
b Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Javier De Las Rivas
Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL)
Co-authored papers 1
Pak-Kei Chan
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Release 1.2